In the last trading session, 8.51 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 1.92. Most recently the company’s share price was $0.65, and it changed around $0.03 or 5.25% from the last close, which brings the market valuation of the company to $75.98M. APLT currently trades at a discount to its 52-week high of $10.62, offering almost -1533.85% off that amount. The share price’s 52-week low was $0.60, which indicates that the current value has risen by an impressive 7.69% since then. We note from Applied Therapeutics Inc’s average daily trading volume that its 10-day average is 8.44 million shares, with the 3-month average coming to 6.44 million.
Applied Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.17. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended APLT as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Applied Therapeutics Inc is expected to report earnings per share of -0.19 for the current quarter.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT has showed a green trend with a performance of 5.25% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.7398 on recent trading dayincreased the stock’s daily price by 12.14%. The company’s shares are currently down -23.73% year-to-date, but still down -3.84% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is -43.22% down in the 30-day period. We can see from the shorts that 19.16 million shares have been sold at a short interest cover period of 1.94 day(s).
The consensus price target as assigned by Wall Street analysts is $4.5, which translates to bulls needing to increase their stock price by 85.56% from its current value. Analyst projections state that APLT is forecast to be at a low of $4 and a high of $5.
Applied Therapeutics Inc (APLT) estimates and forecasts
Applied Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -87.59 percent over the past six months and at a 11.27% annual growth rate that is well below the industry average of 16.50%. The year-over-year growth rate is expected to be -94.66%, down from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 100k in revenue for the current quarter. 3 analysts expect Applied Therapeutics Inc to make 12.32M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 6,382.46%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.72%.
APLT Dividends
Applied Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.80% of Applied Therapeutics Inc shares, and 106.70% of them are in the hands of institutional investors. The stock currently has a share float of 113.26%. Applied Therapeutics Inc stock is held by 177.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 8.1496% of the shares, which is about 10.21 million shares worth $47.69 million.
VR ADVISER, LLC, with 7.6149% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF were the top two Mutual Funds as of Sep 30, 2024 . The former held 3.15 shares worth $2.06 million, making up 2.71% of all outstanding shares. On the other hand, Simplify Exchange Traded Fds-Simplify Propel Opportunities ETF held roughly 2.82 shares worth around $1.84 million, which represents about 2.42% of the total shares outstanding.
